{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T04:16:52Z","timestamp":1774585012446,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/nrrheum.2009.105","type":"journal-article","created":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T06:57:56Z","timestamp":1246431476000},"page":"405-410","source":"Crossref","is-referenced-by-count":53,"title":["Preventing and treating biologic-associated opportunistic infections"],"prefix":"10.1038","volume":"5","author":[{"given":"Kevin L.","family":"Winthrop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Chiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl. 3","key":"BFnrrheum2009105_CR1","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1136\/ard.2008.100834","volume":"67","author":"DE Furst","year":"2008","unstructured":"Furst, D. E. et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008. Ann. Rheum. Dis. 67 (Suppl. 3), iii2\u2013iii25 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2009105_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ncprheum0336","volume":"2","author":"KL Winthrop","year":"2006","unstructured":"Winthrop, K. L. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat. Clin. Prat. Rheumatol. 2, 602\u2013610 (2006).","journal-title":"Nat. Clin. Prat. Rheumatol."},{"key":"BFnrrheum2009105_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/art.23721","volume":"15","author":"KG Saag","year":"2008","unstructured":"Saag, K. G. et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 15, 762\u2013784 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2009105_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1086\/426434","volume":"40","author":"F Tissot","year":"2005","unstructured":"Tissot, F., Zanetti, G., Francioli, P., Zellweger, J. P. & Zysset, F. Influence of bacille Calmette\u2013Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin. Infect. Dis. 40, 211\u2013217 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrrheum2009105_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai, M., Riley, L. W. & Colford, J. M. Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4, 761\u2013776 (2004).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrrheum2009105_CR6","first-page":"620","volume":"137","author":"C Beglinger","year":"2007","unstructured":"Beglinger, C. et al. Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med. Wkly 137, 620\u2013622 (2007).","journal-title":"Swiss Med. Wkly"},{"key":"BFnrrheum2009105_CR7","first-page":"776","volume":"35","author":"D Ponce de Leon","year":"2008","unstructured":"Ponce de Leon, D. et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J. Rheumatol. 35, 776\u2013781 (2008).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2009105_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/ard.2007.070789","volume":"67","author":"G Matulis","year":"2008","unstructured":"Matulis, G., Juni, P., Villiger, P. M. & Gadola, S. D. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases\u2014performance of a mycobacterium tuberculosis antigen specific IFN-gamma assay. Ann. Rheum. Dis. 67, 84\u201390 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2009105_CR9","first-page":"1271","volume":"35","author":"D Vassilopoulos","year":"2008","unstructured":"Vassilopoulos, D., Stamoulis, N., Hadziyannis, E. & Archimandritis, A. J. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J. Rheumatol. 35, 1271\u20131276 (2008).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2009105_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1183\/09031936.06.00110205","volume":"28","author":"F Piana","year":"2006","unstructured":"Piana, F. et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur. Respir. J. 28, 31\u201334 (2006).","journal-title":"Eur. Respir. J."},{"key":"BFnrrheum2009105_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.autrev.2008.07.011","volume":"8","author":"A Lalvani","year":"2008","unstructured":"Lalvani, A. & Millington, K. A. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun. Rev. 8, 147\u2013152 (2008).","journal-title":"Autoimmun. Rev."},{"key":"BFnrrheum2009105_CR12","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1186\/ar1994","volume":"8","author":"H Hamdi","year":"2006","unstructured":"Hamdi, H. et al. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Res. Ther. 8, R114 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2009105_CR13","doi-asserted-by":"crossref","unstructured":"Winthrop, K. L., Siegel, J. N., Jereb, J., Taylor, Z. & Iademarco, M. F. Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum. 52, 2968\u20132974","DOI":"10.1002\/art.21382"},{"key":"BFnrrheum2009105_CR14","doi-asserted-by":"crossref","unstructured":"British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60, 800\u2013805 (2005).","DOI":"10.1136\/thx.2005.046797"},{"key":"BFnrrheum2009105_CR15","unstructured":"Canadian Tuberculosis Committee. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. Can. Commun. Dis. Rep. 34, 1\u201313 (2008)."},{"key":"BFnrrheum2009105_CR16","unstructured":"[No authors listed] Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161, S221\u2013S247 (2000)."},{"key":"BFnrrheum2009105_CR17","unstructured":"CDC & American Thoracic Society. Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2014United States, 2003. MMWR Morb. Mortal. Wkly Rep. 52, 735\u2013739 (2003)."},{"key":"BFnrrheum2009105_CR18","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona, L. et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum. 52, 1766\u20131772 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2009105_CR19","unstructured":"American Thoracic Society, CDC & Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Reccom. Rep. 52, 1\u201377 (2003)."},{"key":"BFnrrheum2009105_CR20","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1086\/587989","volume":"46","author":"KL Winthrop","year":"2008","unstructured":"Winthrop, K. L., Yamashita, S., Beekman, S. E. & Polgreen, P. M. Mycobacterial and other serious infections in patients receiving anti-TNF and other newly approved biologic therapies; case-finding via the Emerging Infections Network. Clin. Infect. Dis. 46, 1738\u20131740 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrrheum2009105_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1469-0691.2007.01891.x","volume":"14","author":"B Denis","year":"2008","unstructured":"Denis, B. et al. Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment. Clin. Microbiol. Infect. 14, 183\u2013186 (2008).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnrrheum2009105_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/521259","volume":"45","author":"LJ Wheat","year":"2007","unstructured":"Wheat, L. J. et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 45, 807\u2013825 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrrheum2009105_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1086\/514744","volume":"28","author":"DS McKinsey","year":"1999","unstructured":"McKinsey, D. S. et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin. Infect. Dis. 28, 1049\u20131056 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrrheum2009105_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1034\/j.1399-3062.2002.01016.x","volume":"4","author":"GM Vail","year":"2002","unstructured":"Vail, G. M. et al. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl. Infect. Dis. 4, 148\u2013151 (2002).","journal-title":"Transpl. Infect. Dis."},{"key":"BFnrrheum2009105_CR25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3201\/eid1206.060028","volume":"12","author":"L Valdivia","year":"2006","unstructured":"Valdivia, L. et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg. Infect. Dis. 12, 958\u2013962 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrrheum2009105_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0891-5520(02)00040-5","volume":"17","author":"TM Chiller","year":"2003","unstructured":"Chiller, T. M., Galgiani, J. N. & Stevens, D. A. Coccidioidomycosis. Infect. Dis. Clin. North Am. 17, 41\u201357, viii (2003).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"BFnrrheum2009105_CR27","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/art.20454","volume":"50","author":"L Bergstrom","year":"2004","unstructured":"Bergstrom, L. et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 50, 1959\u20131966 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2009105_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E. & Beenhouwer, D. O. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin. Infect. Dis. 38, 1261\u20131265 (2004).","journal-title":"Clin. Infect. Dis."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2009.105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2009.105","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2009.105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:09:35Z","timestamp":1739200175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2009.105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFnrrheum2009105"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2009.105","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}